Diabetic foot ulcer (DFU) is a well-known complication of diabetes and a significant burden on the national health systems. The neutrophil/lymphocyte ratio (NLR) and platelet/lymphocyte ratio are inexpensive and easily accessible biomarkers that have proved to be useful in several inflammatory, infectious and cardiovascular diseases. We carried out a comprehensive review examining the association of NLR and PLR with the onset and progression of DFU. PLR and NLR were significantly increased in patients with DFU, compared with a control group of T2DM patients without DFU, and correlate well with DFU severity, evaluated by Wagner and IWGDF grading scales. In patients with diabetic foot infections (DFI), elevated NLR and PLR were correlated with osteomyelitis, increased risk of amputation, and septic complications. The significance of the elevated value of these biomarkers in DFU is related to chronic hyperglycemia and low-grade systemic inflammation, atherosclerotic and vascular complications, and also the associated septic factor. Serial, dynamic follow-up can provide useful information in planning and monitoring DFU treatment, as well as in risk stratification of these vulnerable patients. Further randomized studies are needed to set the cut-off values with clinical significance.
ZhangYLazzariniPAMcPhailSMvan NettenJJArmstrongDGPacellaRE. Global disability burdens of diabetes-related lower-extremity complications in 1990 and 2016.Diabetes Care. 2020;43(5):964-974.
2.
PapanasNMaltezosE. The diabetic foot: a global threat and a huge challenge for Greece. Hippokratia. 2009, 13(4): 199-204.
3.
AbdissaDAdugnaTGeremaUDerejeD. Prevalence of diabetic foot ulcer and associated factors among adult diabetic patients on follow-up clinic at Jimma medical center, Southwest Ethiopia, 2019: An Institutional-Based Cross-Sectional Study. J Diabetes Res.2020;(2020):4106383.
4.
MessengerGMasoetsaRHussainIDevarajanSJahromiM. Diabetic foot ulcer outcomes from a podiatry led tertiary service in Kuwait. Diabet Foot Ankle. 2018;9(1):1471927.
5.
YazdanpanahLShahbazianHNazariI, et al.Incidence and risk factors of diabetic foot ulcer: a population-based diabetic foot cohort (ADFC Study)-two-year follow-up study. Int J Endocrinol. 2018;2018:7631659.
6.
ZugravuCABaciuAPatrascuDTarceaM, Pantea Stoian A: Depression and diabetes: are there any consequences on self-care?, Eur J Public Health. 2012;22(2): 272-272.
7.
ArmstrongDGSwerdlowMAArmstrongAAConteMSPadulaWVBusSA. Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer. J Foot Ankle Res. 2020;13(1):16.
8.
OrasanuGPlutzkyJ. The pathologic continuum of diabetic vascular disease. J Am Coll Cardiol. 2009;53(5 Suppl):S35-42.
9.
ChawlaAChawlaRJaggiS. Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?Indian J Endocrinol Metab. 2016;20(4):546-551.
BuyukkayaEKarakaşMFKarakaşE, et al. Correlation of neutrophil to lymphocyte ratio with the presence and severity of metabolic syndrome. Clin Appl Thromb Hemost. 2014;20(2):159-163.
12.
AkbogaMKCanpolatUYukselM, et al. Platelet to lymphocyte ratio as a novel indicator of inflammation is correlated with the severity of metabolic syndrome: A single center large-scale study. Platelets. 2016;27(2):178-183.
13.
DumanTTAktasGAtakBMKocakMZErkusESavliH. Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus. Afr Health Sci. 2019;19(1):1602-1606.
14.
GasparyanAYAyvazyanLMukanovaUYessirkepovMKitasGD. The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases. Ann Lab Med. 2019;39(4):345-357.
15.
MotomuraTShirabeKManoY, et al. Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment. J Hepatol. 2013;58(1):58-64.
16.
JinHSunJZhuK,et al.The prognostic value of neutrophil-lymphocyte ratio is superior to derived neutrophil-lymphocyte ratio in advanced gastric cancer treated with preoperative chemotherapy and sequential R0 resection: a 5-year follow-up. Onco Targets Ther. 2017 May 22;10:2655-2664.
17.
ChenWChenKXuZ,et al.Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predict mortality in patients with diabetic foot ulcers undergoing amputations. Diabetes Metab Syndr Obes. 2021;14:821-829.
18.
ErenMAGüneşAEKırhanİSabuncuT. The role of the platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in the prediction of lengthand cost of hospital stay in patients with infected diabetic foot ulcers: A retrospective comparative study. Acta Orthop Traumatol Turc. 2020;54(2):127-131.
19.
DemirdalTSenP. The significance of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and lymphocyte-monocyte ratio in predicting peripheral arterial disease, peripheral neuropathy, osteomyelitis and amputation in diabetic foot infection. Diabetes Res Clin Pract. 2018;144:118-125.
20.
OngEFarranSSalloumM, et al. Does everything that’s counted count? value of inflammatory markers for following therapy and predicting outcome in diabetic foot infection. Int J Low Extrem Wounds. 2017;16(2):104-107.
21.
MetinerenHDülgeroğluTC. Comparison of the Neutrophil/Lymphocyte Ratio and C-reactive protein levels in patients with amputation for diabetic foot ulcers. Int J Low Extrem Wounds. 2017;16(1):23-28.
22.
YapıcıOBerkHÖztoprakNSeymanDTahmazAMerdinA. Can ratio of neutrophil-to-lymphocyte count and erythrocyte sedimentation rate in diabetic foot infecti on predict osteomyelitis and/or amputation?Hematol Rep. 2017;9(1):6981.
23.
VatankhahNJahangiriYLandryGJ,et al.Predictive value of neutrophil-to-lymphocyte ratio in diabetic wound healing. J Vasc Surg. 2017;65(2):478-483.
24.
GocerHBuyukcerenICoskunSKeskinDDabakN. Preoperative PLR and NLR values as predictors of mortality in diabetic foot amputations, Biomed Res (India). 2017; 28(4):1629-1632.
25.
KahramanCYümünGKahramanNKNamdarNDCosgunS. Neutrophil-to-lymphocyte ratio in diabetes mellitus patients with and without diabetic foot ulcer. Eur J Med Sci. 2014;1(1):8-13.
26.
AltayFAKuziSAltayM, et al.Predicting diabetic foot ulcer infection using the neutrophil-to-lymphocyte ratio: a prospective study. J Wound Care. 2019;28(9):601-607.
27.
ArıcanGKahramanHÇÖzmeriçAİltarSAlemdaroğluKB. Monitoring the prognosis of diabetic foot ulcers: predictive value of neutrophil-to-lymphocyte ratio and red blood cell distribution width. Int J Low Extrem Wounds. 2020;19(4):369-376.
28.
Aragón-SánchezJVíquez-MolinaGLópez-ValverdeMEAragón-HernándezJRojas-BonillaJMMurillo-VargasC. Clinical, microbiological and inflammatory markers of severe diabetic foot infections. Diabet Med. 2021;38(10):e14648. doi: 10.1111/dme.14648. Epub 2021 Jul 22.
29.
MineokaYIshiiMHashimotoYYamashitaANakamuraNFukuiM. Platelet to lymphocyte ratio correlates with diabetic foot risk and foot ulcer in patients with type 2 diabetes. Endocr J. 2019;66(10):905-913.
30.
ZhangKDingSLyuXTanQWangZ. Correlation between the platelet–to–lymphocyte ratio and diabetic foot ulcer in patients with type 2 diabetes mellitus. J Clin Lab Anal. 2021; e23719.
31.
BhatTTeliSRijalJ, et al. Neutrophil to lymphocyte ratio and cardiovascular diseases: A review. Expert Rev Cardiovasc Ther. 2013;11(1):55-59.
32.
VerdoiaMSchafferABarbieriL,et al.De Luca G; Novara Atherosclerosis Study Group (NAS). Impact of diabetes on neutrophil-to-lymphocyte ratio and its relationship to coronary artery disease. Diabetes Metab. 2015;41(4):304-311.
33.
NijmJWikbyATompaAOlssonAGJonassonL. Circulating levels of proinflammatory cytokines and neutrophil-platelet aggregates in patients with coronary artery disease. Am J Cardiol. 2005;95:452-456.
34.
TanTPArekapudiAMethaJPrasadAVenkatraghavanL. Neutrophil-lymphocyte ratio as predictor of mortality and morbidity in cardiovascular surgery: a systematic review. ANZ Journal of Surgery. 2015;85(6):414-419.
35.
CoelhoNHCoelhoAAugustoR, et al. Pre-operative neutrophil to lymphocyte ratio is associated with 30 day death or amputation after revascularisation for acute limb ischaemia. Eur J Vasc Endovasc Surg. 2021;62(1):74-80.
36.
JiSZhangJFanX,et al.The relationship between mean platelet volume and diabetic retinopathy: a systematic review and meta-analysis. Diabetol Metab Syndr. 2019;11:25.
37.
AdaikalakoteswariARemaMMohanVBalasubramanyamM. Oxidative DNA damage and augmentation of poly (ADP–ribose) polymerase/nuclear factor–kappa B signaling in patients with type 2 diabetes and microangiopathy. Int J Biochem Cell Biol. 2007; 39(9): 1673-1684.
38.
KimBJChoSHChoKIKimHSHeoJHChaTJ. The combined impact of neutrophil–to–lymphocyte ratio and type 2 diabetic mellitus on significant coronary artery disease and carotid artery atherosclerosis. J Cardiovasc Ultrasound. 2016; 24(2): 115- 122.
39.
LiXShenJLuZChenMFangXWangG. High neutrophil–to–lymphocyte ratio is associated with increased carotid artery intima–media thickness in type 2 diabetes. J Diabetes Investig. 2017; 8(1): 101-107.
40.
ForgetPKhalifaCDefourJPLatinneDVan PelMCDe KockM. What is the normal value of the neutrophil-to-lymphocyte ratio?BMC Res Notes. 2017;10(1):12.
41.
MoosazadehMMalekiIAlizadeh-NavaeiR, et al.Normal values of neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and platelet-to-lymphocyte ratio among Iranian population: Results of Tabari cohort. Caspian J Intern Med. 2019;10(3):320-325.
42.
AlexanderNI. Reference values of neutrophil-lymphocyte ratio, plateletlymphocyte ratio and mean platelet volume in healthy adults in north central Nigeria. J Blood Lymph2016; 6: 143-145.
43.
FestJRuiterRIkramMAVoortmanTvan EijckCHJStrickerBH. Reference values for white blood-cell-based in-flammatory markers in the Rotterdam Study: A population-based prospective cohort study. Sci. Rep. 2018,8:10566.
44.
AzabBCamacho-RiveraMTaioliE. Average values and racial differences of neutrophil lymphocyte ratio among a nationally representative sample of United States subjects. PloS One. 2014;9:e112361.
45.
LeeJSKimNYNaSHYounYHShinCS. Reference values of neutrophil-lymphocyte ratio, lymphocyte-monocyte ratio, platelet-lymphocyte ratio, and mean platelet volume in healthy adults in South Korea. Medicine. 2018;97:e11138.
46.
KweonOJLeeMKKimHJChungJWChoiSHKimHR. Neutropenia and neutrophil-to-lymphocyte ratio in a healthy Korean population: race and sex should be considered. Int J Lab Hematol. 2016;38(3):308-318.
47.
Majnarić LTrticaGuljašSBosnićZŠerićVWittlingerT. Neutrophil-to-Lymphocyte Ratio as a Cardiovascular Risk Marker May Be Less Efficient in Women Than in Men. Biomolecules. 2021;11(4):528.
48.
WuL.ZouS.WangC.TanX.YuM. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in Chinese Han popula-tion from Chaoshan region in South China. BMC Cardiovasc. Disord. 2019,19(1):125.
49.
HowardRScheinerAKanetskyPAEganKM. Sociodemographic and lifestyle factors associated with the neutro-phil-tolymphocyte ratio. Ann. Epidemiol. 2019;38:11-21.e6
50.
TongPCLeeKFSoWY, et al. White bloodcell count is associated with macro- and microvascular complications in Chinese patients with type 2 diabetes. Diabetes Care2004;27(1):216-222.
51.
EsserNLegrand-PoelsSPietteJScheenAJPaquotN. Inflammation asa link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract2014;105(2):141-150.
52.
XuHBarnesGTYangQ, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112(12):1821-1830.
53.
RajwaniACubbonRMWheatcroftSB. Cell-specific insulin resistance: implications for atherosclerosis. Diabetes Metab Res Rev. 2012;28(8):627-634.
54.
SantosCPicoitoJTeixeiraALRodriguesaCFerreiraS. Platelet to lymphocyte ratio and homeostasis model assessment of insulin resistance in pediatric obesity and overweight. Rev Port Endocrinol Diabetes Metab. 2017;12(2):177-182
55.
LeeCTHarrisSBRetnakaranR, et al. White blood cell subtypes, insulin resistance and _-cell dysfunc-tion in high-risk individuals – the PROMISE cohort. Clin Endocrinol (Oxf)2014;81(4):536-541.
56.
LouMLuoPTangR,et al.Relationship between neutrophil-lymphocyte ratio and insulin resistance in newly diagnosed type 2 diabetes mellitus patients. BMC Endocr Disord. 2015;15:9.
57.
TurkmenKGuneyIYerlikayaFHTonbulHZ. The relationship between neutrophil-to-lymphocyte ratio and inflammation in end-stage renal disease patients. Ren. Fail. 2012; 34(2): 155-159.
58.
SuceveanuAIStoianAPParepaI, et al.Gut Microbiota Patterns in Obese and Type 2 Diabetes (T2D) Patients from Romanian Black Sea Coast Region. Rev. Chim.[internet]. 2018;69(8):2260-2267.
59.
ShoelsonSLeeJGoldfineA. Inflammation and insulin resistance. J Clin Invest. 2006;116(8):2308.
60.
LiuCCKoHJLiuWS,et al.Neutrophil-to-lymphocyte ratio as a predictive marker of metabolic syndrome. Medicine (Baltimore). 2019;98(43):e17537.
61.
SurendarJIndulekhaKMohanVPradeepaR. Association of neutrophil-lymphocyte ratio with metabolic syndrome and its components in Asian Indians (CURES-143). J Diabetes Complications. 2016;30(8):1525-1529.
62.
HussainMBabarMZMAkhtarLHussainMS. Neutrophil lymphocyte ratio (NLR): A well assessment tool of glycemic control in type 2 diabetic patients. Pak J Med Sci. 2017;33(6):1366-1370.
63.
SefilFUlutasKTDokuyucuR, et al.Investigation of neutrophil lymphocyte ratio and blood glucose regulationin patients with type 2 diabetes mellitus. J Int Med Res. 2014;42(2):581-588.
64.
UmaraniSKKeertiS, Bharati M: Study of Neutrophil-Lymphocyte ratio (NLR) in diabetes mellitus. Tropical J Pathol Microbiol. 2020;6(4):298-302.
65.
LiuNShengJPanTWangY. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio are Associated with Lower Extremity Vascular Lesions in Chinese Patients with Type 2 Diabetes. Clin Lab. 2019;65(3). doi: 10.7754/Clin.Lab.2018.180804
66.
WanHWangYFangS,et al.Associations between the neutrophil-to-lymphocyte ratio and diabetic complications in adults with diabetes: a cross-sectional study. J Diabetes Res. 2020;2020:6219545.
67.
XuTWengZPeiC,et al.The relationship between neutrophil-to-lymphocyte ratio and diabetic peripheral neuropathy in Type 2 diabetes mellitus. Medicine (Baltimore). 2017;96(45):e8289.
68.
WangJRChenZYangK,. et al. Association between neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and diabetic retinopathy among diabetic patients without a related family history. Diabetol Metab Syndr. 2020;12:55.
69.
KhandareSAChittawarSNaharNDubeyTNQureshiZ. Study of neutrophil-lymphocyte ratio as novel marker for diabetic nephropathy in type 2 diabetes. Indian J Endocrinol Metab. 2017;21(3):387-392.
70.
DuanSSunLZhangC,et al.Association of platelet-to-lymphocyte ratio with kidney clinicopathologic features and renal outcomes in patients with diabetic kidney disease. Int Immunopharmacol. 2021;93:107413.
71.
FawwadAButtAMSiddiquiIAKhalidMSabirRBasitA. Neutrophil-to-lymphocyte ratio and microvascular complications in subjects with type 2 diabetes: Pakistan’s perspective. Turk J Med Sci. 2018;48(1):157-161.
72.
MoursyEYMegallaaMHMouftahRFAhmedSM. Relationship between neutrophil lymphocyte ratio and microvascular complications in Egyptian patients with type 2 diabetes. Am J Intern Med. 2015; 3(6): 250-255.
73.
DemirtasLDegirmenciHAkbasEM, et al. Association of hematological indicies with diabetes, impaired glucose regulation and microvascular complications of diabetes. Int J Clin Exp Med. 2015;8(7):11420-11427.
74.
SchneiderDJ. Factors contributing to increased platelet reactivity in people with diabetes. Diabetes Care. 2009;32(4):525-527.
75.
GawazMLangerHMayAE. Platelets in inflammation and atherogenesis. J Clin Invest. 2005; 115(12): 3378-3384.
76.
SchrottmaierWCMussbacherMSalzmannM, Assinger A: Platelet-leukocyte interplay during vascular disease, Atherosclerosis. 2020;307:109-120.
77.
FerreiraIAMockingAIFeijgeMA, et al. Platelet inhibition by insulin is absent in type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol. 2006;26(2):417-422.
78.
KaplarMKappelmayerJVeszpremiASzaboKUdvardyM. The possible association of in vivo leukocyte-platelet heterophilic aggregate formation and the development of diabetic angiopathy. Platelets. 2001;12(7):419-422.
79.
KaurRKaurMSinghJ. Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies. Cardiovasc Diabetol. 2018;17(1):121.
80.
BranzkNLubojemskaAHardisonSE, et al. Neutrophils sense microbe size and selectively release neutrophil extracellular traps in response to large pathogens. Nat Immunol. 2014;15(11):1017-1025.
81.
MenegazzoLCiciliotSPoncinaN, et al. NETosis is induced by high glucose and associated with type 2 diabetes. Acta Diabetologica. 2015,52(3):497-503.
82.
NjeimRAzarWSFaresAHAzarSTKfoury KassoufHEidAA. NETosis contributes to the pathogenesis of diabetes and its complications, J Mol Endocrinol. 2020;65(4):65-76.
83.
FadiniGPMenegazzoLRigatoM, et al. NETosis delays diabetic wound healing in mice and humans. Diabetes. 2016;65(4):1061-1071.
84.
YangCTChenLChenWL, et al. Hydrogen sulfide primes diabetic wound to close through inhibition of NETosis. Mol Cell Endocrinol. 2019;480:74-82.
85.
MenegazzoLScattoliniVCappellariR, et al. The antidiabetic drug metformin blunts NETosis in vitro and reduces circulating NETosis biomarkers in vivo. Acta Diabetologica2018;55(6):593-601.
86.
AppletonNDBaileyDMMorris-StiffGLewisMH. Neutrophil to lymphocyte ratio predicts perioperative mortality following open elective repair of abdominal aortic aneurysms. Vasc Endovascular Surg. 2014;48(4):311-316.
87.
SparkJISarveswaranJBlestNCharalabidisPAsthanaS. An elevated neutrophil-lymphocyte ratio independently predicts mortality in chronic critical limb ischemia. J Vasc Surg. 2010;52(3):632-636.
88.
BhatTMAfariMEGarciaLA. Neutrophil lymphocyte ratio in peripheral vascular disease: a review. Expert Rev Cardiovasc Ther. 2016;14(7):871-875.
89.
BhuttaHAghaRWongJTangTYWilsonYGWalshSR. Neutrophil-lymphocyte ratio predicts medium-term survival following elective major vascular surgery: a cross-sectional study. Vasc Endovascular Surg. 2011;45(3):227-231.
90.
RussellCDParajuliAGaleHJ, et al.The utility of peripheral blood leucocyte ratios as biomarkers in infectious diseases: A systematic review and meta-analysis. J Infect. 2019;78(5):339-348.
91.
GaryTPichlerMBelajK, et al. Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients. PLoS One. 2013;8(7):e67688.
92.
YükselMYıldızAOylumluM,et al.The association between platelet/lymphocyte ratio and coronary artery disease severity. Anatol J Cardiol. 2015;15(8):640-647.
93.
DincTPolat DuzgunAKayiliogluSI, et al. Factors affecting mortality after major nontraumatic lower extremity amputation. Int J Low Extrem Wounds. 2016;15(3):227-231.
